D.E. Shaw & Co’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.74M | Buy |
+237,397
| New | +$6.74M | ﹤0.01% | 1265 |
|
|
2025
Q1 | – | Sell |
-558,969
| Closed | -$16.3M | – | 3291 |
|
|
2024
Q4 | $16.3M | Sell |
558,969
-549,678
| -50% | -$16M | 0.01% | 767 |
|
|
2024
Q3 | $50.9M | Buy |
1,108,647
+369,608
| +50% | +$17M | 0.04% | 316 |
|
|
2024
Q2 | $30.2M | Buy |
739,039
+707,773
| +2,264% | +$28.9M | 0.03% | 428 |
|
|
2024
Q1 | $798K | Sell |
31,266
-10,220
| -25% | -$261K | ﹤0.01% | 2217 |
|
|
2023
Q4 | $375K | Sell |
41,486
-111,793
| -73% | -$1.01M | ﹤0.01% | 2486 |
|
|
2023
Q3 | $978K | Buy |
153,279
+261
| +0.2% | +$1.67K | ﹤0.01% | 2046 |
|
|
2023
Q2 | $1.7M | Sell |
153,018
-233,332
| -60% | -$2.59M | ﹤0.01% | 1825 |
|
|
2023
Q1 | $5.93M | Buy |
386,350
+137,189
| +55% | +$2.11M | 0.01% | 1238 |
|
|
2022
Q4 | $5.53M | Buy |
+249,161
| New | +$5.53M | 0.01% | 1388 |
|